REG - Star Phoenix Group - DIRECTOR APPOINTMENT

Star PhoenixAnnouncement

06/04/2023 16:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230406:nRSF6882Va&default-theme=true

RNS Number : 6882V  Star Phoenix Group Ltd  06 April 2023

6 April 2023

 

Star Phoenix Group Ltd

("Star Phoenix" or the "Company")

 

DIRECTOR APPOINTMENT

Star Phoenix (AIM: STA), an international company with an oilfield services
business in Trinidad and an oil and gas interest in Indonesia, is pleased to
announce the appointment of Dr. Meng YuFeng, the nominee of Beijing Sibo
Investment Management LP ("Sibo"), as an Non-Executive Director to the Board
with immediate effect.

The appointment is made pursuant to para. 7.1 (a) of a subscription agreement
signed in 2015, with Sibo's contractual right to appoint up to three  nominee
directors to the Board of the Company whilst it has a shareholding of above
10%. Pursuant to the subscription agreement, the nominee director is admitted
to the Board until the next annual general meeting of the Company, at which
time the nominee director will be subject to election by shareholders of the
Company.

Dr. Meng's career spans over 30 years across the US, Australia, Hong Kong, and
China where she held various leadership, management and consulting roles in
different sectors including education, aircraft tyre logistics, waste
management, real estate, equity investment, banking and Free Trade Zone
management and marketing. Dr. Meng has experience in the public sector,
project management and finance (particularly in Build-operate-transfer (BOT)
or build-own-operate-transfer (BOOT) project financing). More recently, she
organized numerous government trade delegations to promote bilateral business
cooperation between China and Australia.

Dr Meng holds a PhD in Business Administration from the InterAmerican
University and an MBA in Business Administration from the Southern California
University.

The Directors are pleased to welcome Dr Meng to the Board of the Company and
believe her experience and background will be invaluable as the Company
progresses towards potential new business ventures.

This announcement has been approved by Chairman Lubing Liu on behalf of the
Company.

 

AIM rules disclosures

Dr Meng, aged 53, is, or has during the last five years been, a director or
partner of the following companies and partnerships

 Current directorships / partnerships                            Past directorships / partnerships within the last five years
 Guangdong Alisen Film Culture Media Co. Ltd                     Star Phoenix Group Ltd
 Lin Caotang (Guangdong) Ecological Industry Investment Co.,Ltd  North American Property Pty Ltd.
 Shanghai Hang Lun Trading Co Ltd                                Crystal Fortune
 Hanglun (Beijing) Cargo Transportation Co Ltd
 Efopy Super Pty. Ltd.

 Dr. Meng does not hold any interest in the share capital of the Company.

 Contact Details

                                                                      WH Ireland Limited (Nominated Adviser and Broker)

 Star Phoenix Group Ltd                                               James Joyce / Enzo Aliaj

 Robin Luo (Company Secretary)                                        t.   +44 (0)20 7220 1666

 e. admin@starphoenixgroup.com (mailto:admin@starphoenixgroup.com)

 t.   +61 8 6205 3012

 

This announcement contains inside information for the purposes of Article 7 of
the UK version of Regulation (EU) No 596/2014 which is part of UK law by
virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon
the publication of this announcement via a Regulatory Information Service,
this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUPURGCUPWGAQ